Impax Asset Management Group PLC Karuna Therapeutics, Inc. Transaction History

Impax Asset Management Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$93.97 - $143.33 $4.7 Million - $7.17 Million	-50,000 Reduced 50.27%	49,463 $6.26 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $585,174 - $843,066	5,289 Added 5.62%	99,463 $13 Million
Q3 2021 Nov 12, 2021	BUY	$101.2 - $125.87 $1.99 Million - $2.48 Million	19,711 Added 26.47%	94,174 $11.5 Million
Q2 2021 Aug 05, 2021	BUY	$107.45 - $135.95 $586,247 - $741,743	5,456 Added 7.91%	74,463 $8.49 Million
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $613,651 - $890,989	8,157 Added 13.41%	69,007 $7.01 Million
Q3 2020 Nov 12, 2020	BUY	$71.31 - $109.74 $1.19 Million - $1.83 Million	16,700 Added 37.83%	60,850 $4.71 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $2.74 Million - $5.17 Million	44,150 New	44,150 $4.92 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.